secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001493152-25-013881
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix prices $2M registered direct offering of common stock and prefunded warrants at $7.01
--------------------------------------------------------------------------------

- Offering of 74,114 common shares and prefunded warrants for 217,090 shares at $7.01 per share (or $7.009 per warrant).
- Gross proceeds of ~$2.0M; net proceeds ~$1.8M after placement fees and expenses.
- Proceeds to be used for working capital, repayment of debt and/or redemption of preferred stock.
- Palladium Capital Group acted as exclusive placement agent; closing expected September 17, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225013881/0001493152-25-013881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225013881/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer